glp 1 이란 혈당·체중·심혈관까지… 대세로 떠오른 일석N조' GLP-1 대사 질환 연구에 혁신을 가져오는

Since sodium/glucose cotransporter-2 (SGLT-2) inhibitor treatment reduces CV events as well (with the effect mainly driven by a reduction in heart failure complications), the individual risk of ischemic or heart failure complications should guide the choice of treatment

doi:10.1042/CS20140725 (2015)

More serious but rare risks include pancreatitis and gallbladder disease

PlexusDx recommends disclosing any history of gallbladder removal during your initial health evaluation so your provider can assess your candidacy and establish appropriate monitoring

The use of more than one antidiabetic medication was reported in 73 (46.8%) cases

[DOI] [PMC free article] [PubMed] [Google Scholar] [202].Malkov D, Angelo R, Wang HZ, Flanders E, Tang H, Gomez-Orellana I, Oral delivery of insulin with the eligen technology: mechanistic studies, Curr Drug Deliv, 2 (2005) 191197